-
Posted by
Two Blokes Jul 30 -
Filed in
Stock
-
3 views
British drugmaker GSK said on Wednesday it is in talks with the Trump administration about ways to lower U.S. drug costs, becoming the latest pharmaceutical company to acknowledge action under pressure from Washington to rein in prices.
